Alternative Investment Instruments
Interim Results to 30 June 2025 | 30-Sep-2025 | 07:00 | RNS |
Proposed Acquisition of Clinical Stage Company | 08-Sep-2025 | 07:00 | RNS |
Lyramid SPA 2nd Extension & Carve Out | 28-Aug-2025 | 07:00 | RNS |
Director/PDMR Shareholding | 07-Jul-2025 | 07:00 | RNS |
Director/PDMR Shareholding | 30-Jun-2025 | 07:00 | RNS |
Lyramid SPA Extension | 27-Jun-2025 | 07:00 | RNS |
Results of AGM | 26-Jun-2025 | 13:00 | RNS |
Issue of Equity | 13-Jun-2025 | 16:00 | RNS |
Notice of Annual General Meeting | 02-Jun-2025 | 07:00 | RNS |
Extension of Convertible Loan Notes | 23-May-2025 | 07:00 | RNS |
Corporate Update | 13-May-2025 | 07:00 | RNS |
Annual Report & Financial Statements - 31 Dec 2024 | 30-Apr-2025 | 07:00 | RNS |
Private Placing and Conversion of CLNs | 14-Mar-2025 | 07:00 | RNS |
Board Changes | 10-Mar-2025 | 07:30 | RNS |
Proposed Sale of Oncogeni Ltd | 10-Mar-2025 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 2.09p |
Change Today | 0.086p |
% Change | 4.29 % |
52 Week High | 6.25p |
52 Week Low | 1.23p |
Volume | 166,156 |
Shares Issued | 157.44m |
Market Cap | £3.28m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
09:37 | 25,000 @ 1.95p |
09:33 | 452 @ 2.20p |
09:33 | 300 @ 2.20p |
09:33 | 25 @ 1.80p |
09:33 | 200 @ 2.20p |
You are here: research